Phase Ib results of bemarituzumab (BEMA)+mfolfox6+nivolumab (NIVO) for advanced gastric/ gastroesophageal junction cancer (G/GEJC): Fortitude-102 part 1

Wainberg, ZA; Yamaguchi, K; Ajani, JA; Chao, J; Moehler, M; Kang, YK; Van Cutsem, E; Yen, P; Motii, Y; Zhou, D; Dos Santos, TM; Shitara, K

ANNALS OF ONCOLOGY, 2023; 34 (): S859

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索